These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37314653)

  • 41. Post-licensure zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in older adults: a systematic review and meta-analysis.
    Mbinta JF; Nguyen BP; Awuni PMA; Paynter J; Simpson CR
    Lancet Healthy Longev; 2022 Apr; 3(4):e263-e275. PubMed ID: 36098300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis and treatment of varicella-zoster virus infection with herpetic visceral neuralgia without rash: A case report.
    Zeng J; Yang Y
    Medicine (Baltimore); 2023 May; 102(21):e33766. PubMed ID: 37233427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholera in selected countries in Asia.
    Lopez AL; Dutta S; Qadri F; Sovann L; Pandey BD; Bin Hamzah WM; Memon I; Iamsirithaworn S; Dang DA; Chowdhury F; Heng S; Kanungo S; Mogasale V; Sultan A; Ylade M
    Vaccine; 2020 Feb; 38 Suppl 1():A18-A24. PubMed ID: 31326255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of herpes zoster (shingles) and postherpetic neuralgia.
    Stankus SJ; Dlugopolski M; Packer D
    Am Fam Physician; 2000 Apr; 61(8):2437-44, 2447-8. PubMed ID: 10794584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Herpes zoster and postherpetic neuralgia.
    Johnson RW
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):21-6. PubMed ID: 20192714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic review of incidence and complications of herpes zoster: towards a global perspective.
    Kawai K; Gebremeskel BG; Acosta CJ
    BMJ Open; 2014 Jun; 4(6):e004833. PubMed ID: 24916088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
    Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
    Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology of Herpes Zoster in Adults in Mexico: A Retrospective Database Analysis.
    Guzman-Holst A; Cervantes-Apolinar MY; Favila JCT; Huerta-Garcia G
    Infect Dis Ther; 2023 Jan; 12(1):131-141. PubMed ID: 36348227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review.
    Pan CX; Lee MS; Nambudiri VE
    Ther Adv Vaccines Immunother; 2022; 10():25151355221084535. PubMed ID: 35340552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia.
    Kawai K; Rampakakis E; Tsai TF; Cheong HJ; Dhitavat J; Covarrubias AO; Yang L; Cashat-Cruz M; Monsanto H; Johnson K; Sampalis JS; Acosta CJ
    Int J Infect Dis; 2015 May; 34():126-31. PubMed ID: 25841633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Herpes zoster (shingles) and postherpetic neuralgia.
    Sampathkumar P; Drage LA; Martin DP
    Mayo Clin Proc; 2009 Mar; 84(3):274-80. PubMed ID: 19252116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genital Herpes Zoster as Possible Indicator of HIV Infection.
    Ljubojević Hadžavdić S; Kovačević M; Skerlev M; Zekan Š
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):337-338. PubMed ID: 30665486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Herpes zoster and postherpetic neuralgia in Catalonia (Spain).
    Salleras L; Salleras M; Salvador P; Soldevila N; Prat A; Garrido P; Domínguez A
    Hum Vaccin Immunother; 2015; 11(1):178-84. PubMed ID: 25483532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Herpes Zoster (Shingles) Patient-Centered Wound Outcomes: A Literature Review.
    Bolton LL; Faller N; Kirsner RS
    Adv Skin Wound Care; 2021 May; 34(5):239-248. PubMed ID: 33852460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel vaccine (Zostavax) to prevent herpes zoster.
    Holcomb K; Weinberg JM
    G Ital Dermatol Venereol; 2008 Apr; 143(2):119-23. PubMed ID: 18833038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early Diagnosis of Herpes Zoster Neuralgia: A Narrative Review.
    Fan HR; Zhang EM; Fei Y; Huang B; Yao M
    Pain Ther; 2023 Aug; 12(4):893-901. PubMed ID: 37129752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perceptions of health and coping strategies among temporary migrant workers in East and Southeast Asia: a systematic review.
    Turnbull M; Ching T; Yu C
    Int J Equity Health; 2023 Feb; 22(1):32. PubMed ID: 36793072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition.
    Harvey M; Prosser LA; Rose AM; Ortega-Sanchez IR; Harpaz R
    Pain; 2020 Feb; 161(2):361-368. PubMed ID: 31599852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteopathic Manipulative Treatment of Herpes Zoster Ophthalmicus/Postherpetic Neuralgia.
    Volokitin M; Izadi N; Myers R; Kane Diaw N; Milani S
    Cureus; 2021 May; 13(5):e14906. PubMed ID: 34113516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.